AB Vista is an animal nutrition technology company offering pioneering products and technical services to the global animal feed industry. With its headquarters in the UK, the company employs over 190 staff globally and has support offices worldwide.
Assess feed quality to make smarter nutritional and commercial decisions.
Measure enzyme activity to ensure consistent quality control.
Optimise the feed manufacturing process.
Click on the logos to find out more about our events.
AB Vista is committed to facilitating discussions around animal nutrition technology and gathering experts to provide independent opinions. Our ultimate aim is to research and apply science that brings real value commercially to the animal production industry.
Stay ahead with the latest news, ideas and events.
AB Vista is committed to bringing new ways of thinking to the global feed industry. Our work attracts enquiring minds who see things differently and embrace the changing landscape – offering our clients an interested, innovative and up-to-date partner.
Wednesday, April 26, 2017
Fernando Garcilopez has recently joined AB Vista as Business Manager for Spain, Portugal and Italy.
READ MORE ▶
Tuesday, February 21, 2017
AB Vista continues to grow its ruminant business with the appointment of Nelson Ferreira to the company’s Brazilian team, in the new role of Ruminant Business Manager.
Monday, February 20, 2017
AB Vista returned to IPPE in Atlanta last month for three days of insightful animal feed technology discussions. Here, we share five key insights from our time at the event.
Tuesday, November 29, 2016
AB Vista reveals a successive year of global market share growth driven largely by strong sales of our Quantum Blue and Econase XT enzyme product lines.
Wednesday, November 16, 2016
We have recently expanded our North American team as part of our strategy to strengthen our position in the ruminant market.
A regular summary of our key stories sent straight to your inbox.
Subscribe
Receive a regular summary of our key stories sent straight to your inbox.
A regular summary of our key stories sent straight to your inbox